|
Clinical trials Methodology/study design
Citations 81-90 of 93 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy
- D. J. Loes, A. Fatemi, E. R. Melhem, N. Gupte, L. Bezman, H. W. Moser, and G. V. Raymond
Neurology 2003; 61: 369-374.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN ß-1b
- M. P. Sormani, P. Bruzzi, K. Beckmann, K. Wagner, D. H. Miller, L. Kappos, and M. Filippi
Neurology 2003; 60: 1462-1466.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Inter-rater reliability of a clinical staging of HIV-associated cognitive impairment
- K. Marder, S. M. Albert, M. P. McDermott, J. C. McArthur, G. Schifitto, O. A. Selnes, N. Sacktor, Y. Stern, D. Palumbo, K. Kieburtz, B. Cohen, C. Orme, and L. G. Epstein
Neurology 2003; 60: 1467-1473.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Progressive supranuclear palsy: Setting the scene for therapeutic trials
- Andrew Siderowf and Niall P. Quinn
Neurology 2003; 60: 892-893.
[Full text]
[PDF]
- SPECIAL ARTICLES
Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- M.E. Shy, E.M. Frohman, Y.T. So, J.C. Arezzo, D.R. Cornblath, M.J. Giuliani, J.C. Kincaid, J.L. Ochoa, G.J. Parry, and L.H. Weimer
Neurology 2003; 60: 898-904.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study
- U. Nath, Y. Ben-Shlomo, R.G. Thomson, A.J. Lees, and D.J. Burn
Neurology 2003; 60: 910-916.
[Abstract]
[Full text]
[PDF]
- ARTICLES
MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD
- C. R. Jack, Jr., M. Slomkowski, S. Gracon, T. M. Hoover, J. P. Felmlee, K. Stewart, Y. Xu, M. Shiung, P. C. O’Brien, R. Cha, D. Knopman, and R. C. Petersen
Neurology 2003; 60: 253-260.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Quantitative functional measures in MS: What is a reliable change?
- S. R. Schwid, A. D. Goodman, M. P. McDermott, C. F. Bever, and S. D. Cook
Neurology 2002; 58: 1294-1296.
[Abstract]
[Full text]
[PDF]
- VIEWS & REVIEWS
Clinical trial end points: On the road to nowhere?
- Robert G. Holloway and Andrew W. Dick
Neurology 2002; 58: 679-686.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Surgical therapy for tremor in multiple sclerosis: An evaluation of outcome measures
- J. Matsumoto, D. Morrow, K. Kaufman, D. Davis, J.E. Ahlskog, A. Walker, D. Sneve, J. Noseworthy, and M. Rodriguez
Neurology 2001; 57: 1876-1882.
[Abstract]
[Full text]
[PDF]
|
|
